Home > Drug Search >
  • company_query: Asahi Denka
  •   > 
Drug Filter
Category:
chemistry (18) biology (10)
Status:
Approved (1) Phase Ⅲ (7) Phase Ⅱ (11) Phase Ⅰ (7) IND Filing (2)
Clinical Stage:
Pending (6) Active (12) Discontinued (9)
Bio-Type:
Gene therapy (2) Vaccine (1) Whole antibody (6) Fusion protein (1)
Indication:
Actinic keratosis (AK) (1) Alzheimer's disease (AD) (1) Atherosclerosis (1) Basal cell carcinoma (BCC) (1) Cancer chemotherapy (1) Chronic lymphocytic leukemia (CLL) (1) Delayed graft function (1) Diabetic nephropathy (1) Duodenal ulcer (1) Retinal disorders (1) Hepatocellular carcinoma (HCC) (1) Hyperlipidemia (1) Non small cell lung cancer (NSCLC) (1) Peptic ulcer (1) Peripheral arterial disease (PAD) (1) Postoperative pain (1) Prostate cancer (1) Pulmonary arterial hypertension (1) Rheumatoid arthritis (RA) (1) Solid tumours (4) Superficial basal cell carcinoma (sBCC) (1) Colorectal cancer (1) Ankylosing Spondylitis (AS) (1) Hypoxia (1) Age-related macular degeneration (AMD) (1) Metastatic non-small cell lung cancer (1) Otitis Media (1) External genital and perianal warts (1) Hyperphosphatemia (1) Mesothelioma (1) Diffuse large B cell lymphoma (1) Celiac disease (1) Diabetic neuropathy (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top